RKRuth Koren

Ruth Koren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ruth Koren has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hardship financing of healthcare among rural poor in Orissa, India

    by Erika Binnendijk, Ruth Koren, David M Dror

    Background: This study examines health-related "hardship financing" in order to get better insights on how poor households finance their out-of-pocket healthcare costs. We define hardship financing as having to borrow money with interest or to sell assets to pay out-of-pocket healthcare costs. Methods: Using survey data of 5,383 low-income households in Orissa, one of the poorest states of India, we investigate factors influencing the risk of hardship financing with the use of a logistic regression. Results: Overall, about 25% of the households (that had any healthcare cost) reported hardship financing during the year preceding the survey. Among households that experienced a hospitalization, this percentage was nearly 40%, but even among households with outpatient or maternity-related care around 25% experienced hardship financing. Hardship financing is explained not merely by the wealth of the household (measured by assets) or how much is spent out-of-pocket on healthcare costs, but also by when the payment occurs, its frequency and its duration (e.g. more severe in cases of chronic illnesses). The location where a household resides remains a major predictor of the likelihood to have hardship financing despite all other household features included in the model. Conclusions: Rural poor households are subjected to considerable and protracted financial hardship due to the indirect and longer-term deleterious effects of how they cope with out-of-pocket healthcare costs. The social network that households can access influences exposure to hardship financing. Our findings point to the need to develop a policy solution that would limit that exposure both in quantum and in time. We therefore conclude that policy interventions aiming to ensure health-related financial protection would have to demonstrate that they have reduced the frequency and the volume of hardship financing.


  • Upregulation of MMP‐9 production by TNFα in keratinocytes and its attenuation by vitamin D

    by K. Bahar‐Shany, A. Ravid, R. Koren

    MMP‐9, a member of the matrix metalloproteinase family that degrades collagen IV and processes chemokines and cytokines, participates in epidermal remodeling in response to stress and injury. Limited activity of MMP‐9 is essential while excessive activity is deleterious to the healing process. Tumor necrosis factor (TNFα), a key mediator of cutaneous inflammation, is a powerful inducer of MMP‐9. Calcitriol, the hormonally active vitamin D metabolite, and its analogs are known to attenuate epidermal inflammation. We aimed to examine the modulation of MMP‐9 by calcitriol in TNFα‐treated keratinocytes. The immortalized HaCaT keratinocytes were treated with TNFα in the absence of exogenous growth factors or active ingredients. MMP‐9 production was quantified by gelatin zymography and real‐time RT‐PCR. Activation of signaling cascades was assessed by western blot analysis and DNA‐binding activity of transcription factors was determined by EMSA. Exposure to TNFα markedly increased the protein and mRNA levels of MMP‐9, while pretreatment with calcitriol dose dependently reduced this effect. Employing specific inhibitors we established that the induction of MMP‐9 by TNFα was dependent on the activity of the epidermal growth factor receptor, c‐Jun‐N‐terminal kinase (JNK), NFκB and extracellular signal‐regulated kinase‐1/2. The effect of calcitriol was associated with inhibition of JNK activation and reduction of DNA‐binding activities of the transcription factors activator protein‐1 (AP‐1) and NFκB following treatment with TNFα. By down‐regulating MMP‐9 levels active vitamin D derivatives may attenuate deleterious effects due to excessive TNFα‐induced proteolytic activity associated with cutaneous inflammation. J. Cell. Physiol. 222: 729–737, 2010.


    • 1 August 2009
      • Vol. 130  (2) , 146-54

    Incidence of illness among resource-poor households: evidence from five locations in India.

    by David M. Dror, Olga Van Putten-Rademaker, Ruth Koren

    This study examines the association between household attributes and perceived morbidity within resource-poor house holds (HHs) in India at five locations. This presents an innovation compared to most epidemiological studies, which focus on associations between the incidence of an illness and characteristics of the ill person. Perceived morbidity was represented by a variable called "Incidence of illness in a HH" (IIH) = the number of self reported illness episodes during three months preceding the survey, divided by household size. Variables were analyzed through bivariate correlation and multivariate linear regression. The evidence was based on a HH survey conducted in 2005 in Maharashtra, Bihar, and Tamil Nadu. Data yield reflected responses of 3,531 HHs, representing 17,323 individuals and 4,316 illness episodes. Analysis showed that incidence of illness among women was higher; the under 5 yr olds and elderly (+55) were particularly vulnerable. However, in the multivariate linear regression model, gender ratio within HHs became an insignificant explanatory variable. Age distribution had a small but significant effect. Household size and the level of education in the HH were negatively and significantly associated with IIH. The regression analysis showed that income had a modest positive effect, but improved housing was associated with reduced IIH. Large differences were noted in IIH across locations. Our findings showed that attributes of the unit household, including type of house, income, education and size, have significant effects on IIH; variability in IIH cannot solely be explained by age and gender of HH members.


    • 1 April 2008
      • Vol. 127  (4) , 347-61

    Cost of illness: evidence from a study in five resource-poor locations in India.

    by David M Dror, Olga Van Putten-Rademaker, Ruth Koren

    In India, health services are funded largely through out-of-pocket spendings (OOPS). We carried out this study to collect data on the cost of an illness episode and parameters affecting cost in five locations in India. The data were obtained through a household survey carried out in 2005 in five locations among resource-poor persons in rural India. The analysis was based on self-reported illness episodes and their costs. The study was based on 3,531 households (representing 17,323 persons) and 4,316 illness episodes. The median cost of one illness episode was INR 340. When costs were calculated as per cent of monthly income per person, the median value was 73 per cent of that monthly income, and could reach as much as 780 per cent among the 10 per cent most exposed households. The estimated median per-capita cost of illness was 6 per cent of annual per-capita income. The ratio of direct costs to indirect costs was 67:30. The cost of illness was lower among females in all age groups, due to lower indirect costs. 61 per cent of total illnesses, costing 37.4 per cent of total OOPS, were due to acute illnesses; chronic diseases represented 17.7 per cent of illnesses but 32 per cent of costs. Our study showed that hospitalizations were the single most costly component on average, yet accounted for only 11 per cent of total on an aggregated basis, compared to drugs that accounted for 49 per cent of total aggregated costs. Locations differed from each other in the absolute cost of care, in distribution of items composing the total cost of care, and in supply. Interventions to reduce the cost of illness should be context-specific, as there is no "one-size-fits-all" model to establish the cost of healthcare for the entire sub-continent. Aggregated expenses, rather than only hospitalizations, can cause catastrophic consequences of illness.


  • Two modes of ERK activation by TNF in keratinocytes: Different cellular outcomes and bi‐directional modulation by vitamin D

    by Ester Ziv, Carmela Rotem, Mor Miodovnik, Amiram Ravid, Ruth Koren

    Inflammation, elicited in the skin following tissue damage or pathogen invasion, may become chronic with deleterious consequences. Tumor necrosis factor (TNF) is a key mediator of cutaneous inflammation and the keratinocyte an important protagonist of skin immunity. Calcitriol, the hormonally active vitamin D metabolite, and its analogs attenuate epidermal inflammation and inhibit the hyperproliferation of keratinocytes associated with the inflammatory disorder, psoriasis. Since activation of extracellular signal‐regulated kinase (ERK) promotes keratinocyte proliferation and mediates epidermal inflammation, we studied the effect of calcitriol on ERK activation in HaCaT keratinocytes exposed to the ubiquitous inflammatory cytokine TNF. By using the EGF receptor (EGFR) tyrosine kinase inhibitor, AG1487 and the Src family inhibitor, PP‐1, we established that TNF activated ERK in an EGFR and Src dependent and an EGFR and Src independent modes. EGFR dependent activation resulted in the upregulation of the transcription factor, c‐Fos, while the EGFR independent activation mode was of a shorter duration, did not affect c‐Fos expression but induced IL‐8 mRNA expression. Pretreatment with calcitriol, enhanced TNF‐induced EGFR‐Src dependent ERK activation and tyrosine phosphorylation of the EGFR, but abolished the EGFR‐Src independent ERK activation. These effects were mirrored by enhancement of c‐Fos and inhibition of IL‐8 induction by TNF. Treatment with calcitriol increased the rate of the de‐phosphorylation of activated ERK, accounting for the inhibition of EGFR‐Src independent ERK activation by TNF. It is possible that effects on the ERK cascade contribute to the effects of calcitriol and its synthetic analogs on cutaneous inflammation and keratinocyte proliferation. J. Cell. Biochem. 104: 606–619, 2008.


  • Health insurance benefit packages prioritized by low-income clients in India: Three criteria to estimate effectiveness of choice

    by David Mark Dror, Ruth Koren, Alexander Ost, Erika Binnendijk, Sukumar Vellakkal, Marion Danis


    • 1 August 2006
      • p. 470-5

    Vitamin D receptor defects: the story of hereditary resistance to vitamin D.

    by Ruth Koren

    Vitamin D, synthesized in the epidermis in response to UV radiation, is devoid of any biological activity. The hormonal activity is due to its metabolite, 1 alpha, 25-dihydroxyvitamin D, named calcitriol. The actions of calcitriol are mediated by the vitamin D receptor, VDR, a member of the nuclear receptor family. The clinical presentation of hypocalcaemia, secondary hyperparathyroidism, early onset rickets in the presence of normal levels of serum 25-hydroxyvitamin D and markedly elevated serum levels of calcitriol is indicative of hereditary vitamin D resistant rickets, HVDRR. HVDRR is a recessive autosomal disorder that has been described in approximately 60 unrelated families. Dermal fibroblasts and peripheral blood lymphocytes can serve as target organ models to evaluate the interaction of calcitriol and its effector system. Failure of calcitriol to induce the enzyme 25-hydroxyvitamin D3 24 hydroxylase in fibroblasts or to inhibit lymphocyte mitogenesis can serve as the diagnosis for HVDRR Transfection studies employing site directed mutagenesis to mimic the natural mutations in VDR, have identified mutations that interfere with the major events in VDR signaling: hormone binding; heterodimerization with RXR; binding to vitamin D response elements in the promoters of target genes; and interaction with co- activators. Interference with one or more of these steps results in the clinical syndrome of HVDRR.


  • Vitamin D Enhances Caspase‐Dependent and Independent TNF‐Induced Breast Cancer Cell Death

    by Ge Weitsman, A Ravid, UA Liberman, R Koren

    Abstract: Calcitriol, the hormonal form of vitamin D, enhanced TNF‐induced cytotoxicity in MCF‐7 breast cancer cells. It increased the induction of caspase‐3‐like activity and TNF‐induced caspase‐independent cytotoxicity in the presence of a pan‐caspase inhibitor. The antioxidants N‐acetylcysteine, glutathione, lipoic acid, and ascorbic acid markedly reduced the effect of the hormone on TNF‐induced caspase activation, attesting to the involvement of reactive oxygen species (ROS) in the cross‐talk between the hormone and the cytokine. Calcitriol augmented the drop in mitochondrial membrane potential induced by TNF as assessed by the fluorescent probe JC‐1. We postulate that the interaction of TNF and calcitriol on the level of the mitochondria underlies the enhancement of TNF‐induced, ROS‐mediated caspase‐dependent and ‐independent cell death.